BGMS
Bio Green Med Solution, Inc.Price
Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.
- R Jul 24 BGMS filed Amendment No. 1 to its S-4 registration statement for the…
- X Jul 31 Short interest falls 34.2% to 66.6K
- R Aug 13 BGMS reported Q2 2026 revenue of $336,000 (fire safety distribution)…
- X Aug 31 Short interest falls 40.3% to 34.9K
- E Sep 14 Trading halt: Halt Resumed: BGMS — trading resumed after LUDP (Volatilit…
- X Sep 15 Short interest jumps 160.2% to 90.8K
- X Sep 30 Short interest falls 93.8% to 5.6K
- R Oct 23 BGMS filed an S-3 shelf registration to register 1,103,338 shares fo…
Signal stack
Where each data set points today.
- InstitutionsMIXED
Q2 2026: 2 added (0 new), 0 trimmed or exited.
- TrendRANGE
6% above its 50-day average.
Who's buying
13F· Q2 2026| Fund | Move | Value |
|---|---|---|
| CITADEL ADVISORS LLC | DOUBLED | $68.5K |
| UBS Group AG | ADD | $3.9K |
| RENAISSANCE TECHNOLOGIES LLC | DOUBLED | $46.1K |
| UBS Group AG | DOUBLED | $2.2K |
| UBS Group AG | DOUBLED | $864.00 |
Quarterly 13F filings are due 45 days after each quarter ends.
Earnings setup
Estimates| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | — | — | — | $0.00 |
| Next Q | — | — | — | $0.00 |
| Current FY | — | — | — | $0.00 |
| Next FY | — | — | — | $0.00 |
Short side
FINRA· Oct 15, 2026| Sep 14, 2026 | Volatility Pause | Resumed |
SecBot reports
5 filings · 2 press releases · 0 bullish · 3 bearish · 2 neutral- BEARISH S-3Oct 23, 2026
BGMS filed an S-3 shelf registration to register 1,103,338 shares for resale by selling…
Monitor for the S-3 effectiveness date — once effective, selling stockholders can immediately begin selling into the market. The 16.7% overhang on a $7M cap with limited liquidity creates acute…
- NEUTRAL 8-KOct 16, 2026
Bio Green Med Solution, Inc. declared a quarterly cash dividend of $0.15 per share on its 6%…
Monitor the company's next quarterly report for any changes in preferred dividend coverage or financial health. No immediate read-through for common stock holders.
- NEUTRAL EFFECTOct 9, 2026
Bio Green Med Solution, Inc. received SEC effectiveness for its S-4 registration (File No…
Monitor for any subsequent pricing or prospectus filing (e.g., 424B4/424B3) to see actual terms and dilution impact. The S-4 effectiveness enables the company to proceed with a business combination…
- BEARISH 8-KAug 13, 2026
BGMS reported Q2 2026 revenue of $336,000 (fire safety distribution) and a net loss of $405,000…
The BCA terms confirm that BGMS is being used as a shell for Future NRG's reverse merger. Current shareholders should expect near-total loss of equity value upon closing. Monitor for any termination…
All BGMS filing & press-release reports (7)
- S-3 reportOct 23, 2026
- 8-K reportOct 16, 2026
- EFFECT reportOct 9, 2026
- 8-K reportAug 13, 2026
- S-4/A reportJul 24, 2026
- PRESS-RELEASE reportJun 4, 2026
- PRESS-RELEASE reportMar 30, 2026